Eureka 2019: Rodent Studies Unlock Endocrine Secrets

For the fifth year in a row, Endocrine News spoke with editors from Endocrine Society journals to get the scoop on the top endocrine discoveries of 2019. Here is part 1 of Eureka! 2019.

 

Editor-in-chief Teresa K. Woodruff, PhD, professor of Obstetrics and Gynecology, Medical Social Sciences, and Medicine at the Feinberg School of Medicine at Northwestern University in Chicago, Ill., listed four papers of note from Endocrinology, two on metabolic health and two on development.

In “Sex Differences in Inflammatory Responses to Adipose Tissue Lipolysis in Diet-Induced Obesity,” published in February, Singer, K., et. al. tease out a mechanism underlying sexual dimorphism in metabolic health. Chronic inflammation in obesity can lead to such serious complications as type 2 diabetes, cardiovascular diseases, hypertension, and atherosclerosis. Females exhibit less inflammation in obesity from high-fat diets than do males, and the researchers posit that this difference could be mediated by sex-related variation in lipolytic metabolites. Using a mouse model, they demonstrated that females’ enhanced ability to store gonadal white adipose tissue led to induced adipocyte remodeling.

Sudo, N., et. al. answer an important question about anorexia nervosa that until now had remained unclear. In “The Gut Microbiome Derived from Anorexia Nervosa Patients Impairs Weight Gain and Behavioral Performance in Female Mice,” from October, they show that mice given microbiota from human patients with the restricting type of anorexia nervosa (as opposed to the binge-eating type) ate less and accordingly gained less weight than control mice; exhibited anxiety-related, compulsive behavior; and had lower brainstem serotonin levels. Their ability to convert ingested food to unit of body substance was also impaired. Thus, gut dysbiosis, specifically, lower concentrations of certain species of microorganisms, appears to be a driver of the metabolic and neuropsychiatric abnormalities in anorexia nervosa.

Tsukamura, H., et. al. further elucidate how estrogenic chemicals contribute to male infertility in “Neonatal Estrogen Causes Irreversible Male Infertility via Specific Suppressive Action on Hypothalamic Kiss1 Neurons” from May. Neonatal treatment with estradiol benzoate lasting 10 days resulted in smaller seminiferous tubules, abnormal spermatogenesis, and decreased plasma testosterone in adult male rats. Researchers report that this reproductive dysfunction is likely due to irreversible suppression of kisspeptin–neurokinin B–dynorphin A neurons in the arcuate nucleus from chronic estrogen exposure.

From August, “Transgenerational Bisphenol A Causes Deficits in Social Recognition and Alters Postsynaptic Density Genes in Mice” likewise looks at the effects of endocrine-disrupting chemicals on development. Rissman, E.F., et. al. bred second-generation mice exposed to bisphenol A (BPA) and examined the brains of the offspring with polymerase chain reaction (PCR) after observing their live behavior for a period.

Mice whose great-grandmothers were exposed to BPA during pregnancy showed no curiosity about new mice introduced to the group, which is strikingly aberrant mouse behavior. The researchers found that BPA exposure in third-generation mice disrupted social interactions and caused abnormal expression of excitatory postsynaptic densities genes known to be associated with neurobehavioral disorders like autism and attention deficit hyperactivity disorder. These transgenerational effects of BPA exposure will therefore be seen for some time to come, even if BPA were banned today.

 

 

 

You may also like

  • March 2019: Women in Endocrinology

    Gender inequality persists in all sectors of society, including science and medicine disciplines. While female clinicians and researchers are increasing in number[1], they remain underrepresented in scholarly publications and academic positions[2]. Although nearly 50% of medical school graduates are women, they continue to hold fewer senior academic positions and tenured faculty posts than their male…

  • News from ADA 2018

    Real-World Study of More than 700,000 People with Type 2 Diabetes (T2D) Shows No Increased Risk of Below-Knee Lower Extremity Amputations with Canagliflozin Compared to Other Diabetes Medications A new real-world analysis of more than 700,000 U.S. T2D patients found no increased risk of below-knee lower extremity (BKLE) amputation with canagliflozin compared to other sodium glucose…